Browse by Subject NSCLC

Showing results 1 to 5 of 5

1
Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors in Patients With De Novo EGFR(T790M)-Mutant NSCLC

Park, Ha-Ram; Kim, Tae Min; Lee, Yusoo; Kim, Soyeon; Park, Seongyeol; Ju, Young Seok; Kim, Miso; et al, JOURNAL OF THORACIC ONCOLOGY, v.16, no.11, pp.1859 - 1871, 2021-11

2
Hippo effector YAP directly regulates the expression of PD-L1 transcripts in EGFR-TKI-resistant lung adenocarcilloma

Lee, Byung Soo; Park, Dong Il; Lee, Da-Hye; Lee, Jeong Eun; Yeo, Min-kyung; Park, Yeon Hee; Lim, Dae Sik; et al, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, v.491, no.2, pp.493 - 499, 2017-09

3
Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer

Kim, C. G.; Kim, K. H.; Pyo, K-H; Xin, C-F; Hong, M. H.; Ahn, B-C; Kim, Y.; et al, ANNALS OF ONCOLOGY, v.30, no.7, pp.1104 - 1113, 2019-07

4
MMPP Attenuates Non-Small Cell Lung Cancer Growth by Inhibiting the STAT3 DNA-Binding Activity via Direct Binding to the STAT3 DNA-Binding Domain

Son, Dong Ju; Zheng, Jie; Jung, Yu Yeon; Hwang, Chul Ju; Lee, Hee Pom; Woo, Ju Rang; Baek, Song Yi; et al, THERANOSTICS, v.7, no.18, pp.4632 - 4642, 2017

5
The HSP90 inhibitor, NVP-AUY922, sensitizes KRAS-mutant non-small cell lung cancer with intrinsic resistance to MEK inhibitor, trametinib

Park, Kang-Seo; Oh, Bora; Lee, Mi-Hee; Nam, Ky-Youb; Jin, Hae Ran; Yang, Hannah; Choi, Junyoung; et al, CANCER LETTERS, v.372, no.1, pp.75 - 81, 2016-03

rss_1.0 rss_2.0 atom_1.0